Next Generation Flow Cytometry: What to Know

A laboratory labels cells with markers that attach to selected features on or inside them. Cells pass through an instrument one at a time, and light signals are recorded. Computer analysis groups cells by their patterns. In blood cancers, this can help distinguish normal cells from an abnormal population, describe the population's features, and assess whether a suspected disease pattern is present.

The method depends on a suitable sample, often blood, bone marrow, or another fluid. It is different from sequencing because it measures cell characteristics rather than reading stretches of DNA. Results are interpreted alongside symptoms, blood counts, imaging, pathology, and sometimes a bone marrow biopsy. A result can support a diagnosis without answering every clinical question.

Ask what sample will be collected and whether it must reach the laboratory quickly. Tell the team about medicines, recent treatment, and any difficulty with blood draws. After testing, ask which cell markers were assessed and whether the report found a distinct abnormal population. Request an explanation of any recommended follow-up, such as repeat sampling or additional pathology.

After a blood draw or bone marrow procedure, contact the care team for persistent bleeding, increasing redness or swelling, fever, or worsening pain at the collection site. Seek urgent help for severe weakness, difficulty breathing, fainting, or uncontrolled bleeding. These symptoms need clinical assessment regardless of what the flow cytometry report shows.

What cells are being investigated? Which markers will be measured? Does the sample need another test to confirm the finding? How will this result fit with my blood counts or biopsy? When should I expect an explanation of the report?